Am adding each time this dips below $3.00 IMO a no-brainer given MindMed's pipeline and the pending uplist to the NASDAQ. When the latter happens, you want to be very well loaded with shares vs chasing the big, new $$hare price.
Both of these folks are tied to J&J... I don't think that is a coincidence.
They are working with Linear Clinical Research Ltd in Australia / Perth. Why?
Australian (TGA) clinical trial start-ups are typically 4-6 months faster than US (FDA) trials! Better still, they’re much cheaper – often a third of the cost and exceptional quality. And with our concept-to-commercialisation capabilities, we can compress those timeframes and costs even further.
No IND required Fast-tracked approvals Generous R&D refunds Excellent health system Access to patient databases Data accepted by FDA, EMA, CFDA & PDMA
---
Looks like to me they will fast track in Australia - then partner with J&J if a successful outcome.
News 
Market Data 
Discover 
